Marketing of 666 Cough Syrup in China

Solution Preview

Guidance on Marketing of 666 Cough Syrup in China
Political and Legal Factors and implications for 666 Cough Syrup
China is encouraging the development of low cost generic drugs through promotion of research and development of new high quality drugs which could be low cost alternative to branded medicines (Xinhua, 2018: April 3). Although the government is promoting generic drugs but the stringent regulation under two five year plans from 2016-2020 have made the quality standards high for generic drugs also that shall be at par with international standards (China Food and Drug Administration, 2017: Feb.22). The competition for 666 Cough Syrup will increase due to encouragement of generic drugs but the compliances required may lead to restriction of pharmaceutical drugs manufacturer with lower standards in quality.

Cultural and Language Barriers in China
China is known for its strong cultural heritage in medicines and the traditional Chinese medicines have not only become popular in China but these medicines have also become popular in other parts of the world such as Europe and New York and in Europe as a study reveals that between 2012 and 2017, 36% of all new traditional Chinese medicines were launched in Europe and the usage of Chinese medicines have increased with 93% increase in market share of these medicines in the continent (General, 2018: n.d.). The medicines must be labeled on the package in the Chinese language as is also mandated by the Chinese Food and Drug Administration as it represents their culture and all information relating to quality testing standards, origin, date of ...